Human umbilical cord blood cells and diabetes mellitus: Recent advances

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Stem cell therapy for patients with diabetes is an area of great interest to both scientists and clinicians. Human umbilical cord blood cells (HUCBCs) are being increasingly used as a source of stem cells for cell-based therapy for diabetes because these cells can differentiate into pancreatic islet -cells. Administration of HUCBCs has been shown to lower blood glucose levels in diabetic animal models. The use of autologous HUCBC transfusion in type 1 diabetic children has not shown any benefit. However, “Stem Cell Educator” therapy has shown promise in long term lowering of blood glucose levels in both type 1 and type 2 diabetic patients. In this review, we will briefly discuss recent advances in HUCBC therapy in the treatment of diabetes and some of its complications.

Original languageEnglish (US)
Pages (from-to)266-270
Number of pages5
JournalCurrent Stem Cell Research and Therapy
Issue number3
StatePublished - Jan 1 2015

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)


  • Clinical trials
  • Diabetes mellitus
  • Differentiation
  • Human umbilical cord blood
  • Stem cell educator therapy
  • Stem cells
  • β-cells

Fingerprint Dive into the research topics of 'Human umbilical cord blood cells and diabetes mellitus: Recent advances'. Together they form a unique fingerprint.

Cite this